Skip to main content

Hereditary haemorrhagic telangiectasia treated by pulsed neodymium:yttrium-aluminium-garnet (Nd:YAG) laser (1,064 nm)

Abstract

Hereditary haemorrhagic telangiectasia (HHT) is a familial, autosomal, dominant, multi-system, vascular, dysplasia. Besides repetitive epistaxis, cutaneous eruptive macules and nodules lead to recurring bleeding and cosmetic problems. We report on a pilot study of four cases of HHT in which cutaneous lesions were treated with a pulsed neodymium:yttrium-aluminum-garnet (Nd:YAG) laser (1,064 nm). Pulsed Nd:YAG laser treatment, without anaesthesia, was performed several times on eruptive angiomas on palmar and facial skin. Lesions on fingers and face mostly showed very good, or even complete, clearing after the first laser treatment. Several macules required multiple treatment; only a few lesions showed no effect. Pulsed Nd:YAG laser therapy (1,064 nm) appears to be an effective and safe treatment option for hereditary haemorrhagic telangiectasia on the skin of face and extremities.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. Gluckman PL, Nostrant TT (1994) Modified Young’s procedure for refractory epistaxis due to hereditary hemorrhagic telangiectasia. Laryngoscope 104:1174–1177

    PubMed  Article  CAS  Google Scholar 

  2. Geisthoff UW, Koester M, Fischinger J, Schneider G (2004) Rendu–Osler–Weber syndrome—a complex systemic disease. MMW Fortschr Med 146:33–35

    PubMed  CAS  Google Scholar 

  3. Haye R, Austad J (1992) Hereditary haemorrhagic teleangiectasia: unsuccessful treatment with the flashlamp-pulsed dye laser. Rhinology 30:135–137

    PubMed  CAS  Google Scholar 

  4. Ducic Y, Brownrigg P, Laughlin S (1995) Treatment of haemorrhagic telangiectasia with the flashlamp-pulsed dye laser. J Otolaryngol 24:299–302

    PubMed  CAS  Google Scholar 

  5. Harries PG, Brockbank MJ, Shakespeare PG, Carruth JA (1997) Treatment of hereditary haemorrhagic telangiectasia by the pulsed dye laser. J Laryngol Otol 111:1038–1041

    PubMed  CAS  Google Scholar 

  6. Vickery CL, Kuhn FA (1996) Using the KTP/532 laser to control epistaxis in patients with hereditary hemorrhagic telangiectasia. South Med J 89:78–80

    PubMed  CAS  Google Scholar 

  7. Bergler W, Farin G, Fischer K, Hormann K (1998) Argon plasma surgery (APC) in the upper aerodigestive tract. Initial results. HNO 46:672–677

    PubMed  Article  CAS  Google Scholar 

  8. Werner JA, Lippert BM, Geisthoff UW, Rudert H (1997) Nd:YAG laser therapy of recurrent epistaxis in hereditary hemorrhagic telangiectasia. Laryngorhinootologie 76:495–501

    PubMed  CAS  Google Scholar 

  9. Shapshay SM, Oliver P (1984) Treatment of hereditary hemorrhagic telangiectasia by Nd-YAG laser photocoagulation. Laryngoscope 94:1554–1556

    PubMed  Article  CAS  Google Scholar 

  10. Velegrakis GA, Prokopakis EP, Papadakis CE, Helidonis ES (1997) Nd:YAG laser treatment of recurrent epistaxis in heredity hemorrhagic telangiectasia. J Otolaryngol 26:384–386

    PubMed  CAS  Google Scholar 

  11. Lyons GD, Owens RE, Mouney DF (1981) Argon laser destruction of cutaneous telangiectatic lesions. Laryngoscope 91:1322–1325

    PubMed  Article  CAS  Google Scholar 

  12. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu–Osler–Weber syndrome). Am J Med Genet 91:66–67

    PubMed  Article  CAS  Google Scholar 

  13. Porteous ME, Burn J, Proctor SJ (1992) Hereditary haemorrhagic telangiectasia: a clinical analysis. J Med Genet 29:527–530

    PubMed  CAS  Article  Google Scholar 

  14. Bayrak-Toydemir P, McDonald J, Markewitz B, Lewin S, Miller F, Chou LS, Gedge F, Tang W, Coon H, Mao R (2006) Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations. Am J Med Genet A 140:463–470

    PubMed  Google Scholar 

  15. Plauchu H, de Chadarevian JP, Bideau A, Robert JM (1989) Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 32:291–297

    PubMed  Article  CAS  Google Scholar 

  16. Attisano L, Wrana JL (2002) Signal transduction by the TGF-β superfamily. Science 296:1646–1647

    PubMed  Article  CAS  Google Scholar 

  17. Anderson RR, Parrish JA (1983) Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 220:524–527

    PubMed  Article  CAS  Google Scholar 

  18. van Gemert MJ, Welch AJ, Pickering JW, Tan OT, Gijsbers GH (1995) Wavelength for laser treatment of port wine stains and telangiectasia. Lasers Surg Med 16:147–155

    PubMed  Article  Google Scholar 

  19. Scherer K, Lorenz S, Wimmershoff M, Landthaler M, Hohenleutner U (2001) Both the flashlamp-pumped dye laser and the long-pulsed tunable dye laser can improve results in port-wine stain laser therapy. Br J Dermatol 145:79–84

    PubMed  Article  CAS  Google Scholar 

  20. Chang CJ, Kelly KM, Van Gemert MJ, Nelson JS (2002) Comparing the effectiveness of 585-nm vs 595-nm wavelength pulsed dye laser treatment of port wine stains in conjunction with cryogen spray cooling. Lasers Surg Med 31:352–358

    PubMed  Article  Google Scholar 

  21. Kimel S, Svaasand LO, Cao D, Hammer-Wilson MJ, Nelson JS (2002) Vascular response to laser photothermolysis as a function of pulse duration, vessel type, and diameter: Implications for port wine stain laser therapy. Lasers Surg Med 30:160–169

    PubMed  Article  Google Scholar 

  22. Shafirstein G, Bäumler W, Lapidoth M, Ferguson S, North PE, Waner M (2004) A new mathematical approach to the diffusion approximation theory for selective photothermolysis modeling and its implication in laser treatment of port-wine stains. Lasers Surg Med 34:335–347

    PubMed  Article  Google Scholar 

  23. Haitjema T, Westermann CJ, Overtoom TT, Timmer R, Disch F, Mauser H, Lammers JW (1996) Hereditary hemorrhagic telangiectasia (Osler–Weber–Rendu disease): new insights in pathogenesis, complications and treatment. Arch Intern Med 156:714–719

    PubMed  Article  CAS  Google Scholar 

  24. Braverman TM, Keh A, Jacobson BS (1990) Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J Invest Dermatol 95:422–427

    PubMed  Article  CAS  Google Scholar 

  25. Haina D, Landthaler M, Waidelich W (1981) Physical and biological principles of the use of lasers in dermatology (author’s transl). Hautarzt 32:397–401

    PubMed  CAS  Google Scholar 

  26. Shapshay SM, David LM, Zeitels S (1987) Neodymium-YAG laser and photocoagulation of hemangiomas of the head and the neck. Laryngoscope 97:323–330

    PubMed  CAS  Google Scholar 

  27. Werner JA, Lippert BM, Hoffmann P, Rudert H (1995) Nd:YAG laser therapy of voluminous hemangiomas and vascular malformations. Adv Otorhinolaryngol 49:75–80

    PubMed  CAS  Google Scholar 

  28. Wimmershoff MB, Landthaler M, Hohenleutner U (1999) Percutaneous and combined percutaneous and intralesional Nd:YAG-laser therapy for vascular malformations. Acta Derm Venerol (Stockh) 79:71–73

    Article  CAS  Google Scholar 

  29. Ulrich H, Bäumler W, Hohenleutner U, Landthaler M (2005) Neodymium-YAG laser for hemangiomas and vascular malformations—long term results. J Dtsch Dermatol Ges 6:436–440

    Google Scholar 

  30. Wilder D (1999) Pulsed 1064-nm Nd:YAG laser therapy for noninvasive treatment of a massive hemangioma: case report. J Clin Laser Med Surg 17:245–246

    PubMed  CAS  Google Scholar 

  31. Yang MU, Yaroslavsky AN, Farinelli WA, Flotte TJ, Rius-Diaz F, Tsao S, Anderson RR (2005) Long-pulsed neodymium:yttrium-aluminum-garnet laser treatment for port-wine-stains. J Am Acad Dermatol 52:480–490

    PubMed  Article  Google Scholar 

  32. Sadick NS, Prieto VG, Shea CR, Nicholson J, McCaffrey T (2001) Clinical and patho-physiologic correlates of 1064-nm Nd:YAG laser treatment of reticular veins and venulectasias. Arch Dermatol 137:613–617

    PubMed  CAS  Google Scholar 

  33. Coles CM, Werner RS, Zelickson BD (2002) Comparative pilot study evaluating the treatment of leg veins with a long pulse Nd:YAG laser and sclerotherapy. Lasers Surg Med 30:154–159

    PubMed  Article  Google Scholar 

  34. Eremia S, Li C, Umar S (2002) A side-by-side comparative study of 1064 nm Nd:YAG, 810 diode and 755 nm alexandrite lasers for treatment of 0.3–3 mm leg veins. Dermatol Surg 28:224–230

    PubMed  Article  Google Scholar 

  35. Omura NE, Dover JS, Arndt KA, Kauver AN (2003) Treatment of reticular leg veins with a 1064 nm long-pulsed Nd:YAG laser. J Am Acad Dermatol 48:76–81

    PubMed  Article  Google Scholar 

  36. Levy JL, Ehlbar C, Jouve E, Mordon S (2004) Comparison and sequential study of long pulsed Nd:YAG 1,064 nm laser and sclerotherapy in leg telangiectasias treatment. Lasers Surg Med 34:273–276

    PubMed  Article  Google Scholar 

  37. Bäumler W, Ulrich H, Hartl M, Landthaler M, Shafirstein G (2006) Optimal parameters for the treatment of leg veins using Nd:YAG lasers at 1064 nm. Br J Dermatol 155:364–371

    PubMed  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to A. Werner.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Werner, A., Bäumler, W., Zietz, S. et al. Hereditary haemorrhagic telangiectasia treated by pulsed neodymium:yttrium-aluminium-garnet (Nd:YAG) laser (1,064 nm). Lasers Med Sci 23, 385–391 (2008). https://doi.org/10.1007/s10103-007-0512-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10103-007-0512-4

Keywords

  • Nd:YAG laser (1,064 nm)
  • Osler’s disease
  • Hereditary haemorrhagic telangiectasia (HHT)